The effect of PAF (platelet-activating factor) on experimental cardiac arrhythmias and its inhibition by substances influencing arachidonic acid metabolites

Prostaglandins, Leukotrienes and Medicine - Tập 28 - Trang 103-109 - 1987
A. Riedel1, H.-J. Mest1
1Dep. of Pharmacology and Toxicology, Martin Luther University, Leninallee 4, Halle, 4020, GDR

Tài liệu tham khảo

Benveniste, 1972, Leukocyte-dependent histamine release from rabbit platelets I. The role of IgE, basophils and a platelet-activating factor, J Exp Med, 136, 1356, 10.1084/jem.136.6.1356 Braquet P, Touqui L, Shen Y, Vargaftig BB Perspectives in platelet-activating factor research J Med Chem (in press) Ezra, 1985, Effects of platelet-activating factor on coronary hemodynamics and coronary venous plasma levels of TXB2, 6-keto-PGF and leukotriene C4 immunoreactivity in the intactla and pig heart, Vol 13, 19 Voelkel, 1982, Non-immunologic production of leukotrienes induced by platelet-activating factor, Science, 218, 286, 10.1126/science.7123233 Levi, 1980, Cardiac anaphylaxis: SRS-A potentiates and extends the effects of released histamine, Eur J Pharmacol, 62, 41, 10.1016/0014-2999(80)90479-3 Mest, 1978, The antiarrhythmic action of prostacyclin (PGI2) on aconitine induced arrhythmia in rats, Acta biol germ, 37, 827 Coker, 1981, The effects of PGE , PGF2α, flurbiprofen and ASA on arrhythmias resulting from coronary artery ligation in anaesthetized rats, Br J Pharmacol, 74, 155, 10.1111/j.1476-5381.1981.tb09968.x Mest, 1986, Significance of the thromboxane-prostacyclin balance for cardiac rhythm disturbances abstract, 461 Tamargo, 1985, Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles, Eur J Pharmacol, 109, 219, 10.1016/0014-2999(85)90423-6 Camussi, 1984, Effect of platelet-activating factor on guinea-pig papillary muscle, Experentia, 40, 697, 10.1007/BF01949729 Levi, 1984, Acethyl glyceryl ether phosphorylcholine. A putative mediator of cardiac anaphylaxis in the guinea-pig, Circ Res, 54, 117, 10.1161/01.RES.54.2.117 Stegmeier, 1984, The pharmacological profile of the thromboxane A2 antagonist BM 13.177, a new anti-platelet and anti-thrombotic drug, Thrombosis Res, 35, 379, 10.1016/0049-3848(84)90230-5 Sekiya, 1982, Selective inhibition of platelet lipoxygenase by esculetin, Biochim Biophys Acta, 713, 68, 10.1016/0005-2760(82)90167-9